Multislit Collimator Research Articles

Image reconstruction for interrupted-beam x-ray CT on diagnostic clinical scanners

Low-dose x-ray CT is a major research area with high clinical impact. Compressed sensing using view-based sparse sampling and sparsity-promoting regularization has shown promise in simulations, but these methods can be difficult to implement on diagnostic clinical CT scanners since the x-ray beam cannot be switched on and off rapidly enough. An alternative to view-based sparse sampling is interrupted-beam sparse sampling. SparseCT is a recently-proposed interrupted-beam scheme that achieves sparse sampling by blocking a portion of the beam using a multislit collimator (MSC). The use of an MSC necessitates a number of modifications to the standard compressed sensing reconstruction pipeline. In particular, we find that SparseCT reconstruction is feasible within a model-based image reconstruction framework that incorporates data fidelity weighting to consider penumbra effects and source jittering to consider the effect of partial source obstruction. Here, we present these modifications and demonstrate their application in simulations and real-world prototype scans. In simulations compared to conventional low-dose acquisitions, SparseCT is able to achieve smaller normalized root-mean square differences and higher structural similarity measures on two reduction factors. In prototype experiments, we successfully apply our reconstruction modifications and maintain image resolution at quarter-dose reduction level. The SparseCT design requires only small hardware modifications to current diagnostic clinical scanners, opening up new possibilities for CT dose reduction.

Optimization of single-photon emission computed tomography system for fast verification of spent fuel assembly: a Monte Carlo study

The International Atomic Energy Agency (IAEA) assessed that single-photon emission computed tomography (SPECT) technique is one of the most attractive technique for safeguards of a spent fuel because of its intuitive evaluation capability by using a tomographic image. Even though there are over a hundred kinds of the verification technique, the IAEA suggested the need for “more sensitive and less intrusive alternatives to existing nondestructive assay instruments” for partial-defect detection. The aim of this study is to optimize a SPECT system using Monte Carlo method for faster verification of spent fuel assembly than the conventional system. An optimization study of detector geometry was performed using GATE simulation program. The detector head consists of one-dimensional (1D) multi-slit tungsten collimator, Bismuth Germanate (BGO) scintillator, and silicon photomultiplier (SiPM) arrays. The collimator slit width and length, and scintillator length were optimally determined by evaluating the quality of 1D projection image for Cs-137 line source. The type of photoelectric sensor was determined by assessing the light transfer efficiency of the scintillator using DETECT2000 program. For the performance evaluation of the optimized detector, a tomographic image of twelve fuel sources in the assembly was compared with that acquired using the conventional detector developed by IAEA . The optimized scintillator length, collimator slit width, length, and septal thickness were 4 cm, 0.2 cm, 5 cm, and 0.2 cm, respectively. The light transfer efficiency in the scintillator to the 3×70 mm3 and 3×3 mm2 sensors were 23.4± 0.6% and 5.3± 0.3%, respectively. In the results of the image quality assessment, the optimized detector head shows about 1.5 times improved sensitivity, while the image quality is slightly poorer than the conventional one due to the bigger slit width. Nevertheless, by considering a deep-learning-based image-reconstruction-algorithm, we chose the bigger slit width because higher image intensity gives an advantage in discrimination between the fuel sources and the background noise. We expect that the combination of the detector head with higher sensitivity and the deep-learning-based image-reconstruction-algorithm will contribute to the faster verification of spent fuel assemblies compared to the conventional system.

SparseCT: System concept and design of multislit collimators.

SparseCT, an undersampling scheme for compressed sensing (CS) computed tomography (CT), has been proposed to reduce radiation dose by acquiring undersampled projection data from clinical CT scanners (Koesters etal. in, SparseCT: Interrupted-Beam Acquisition and Sparse Reconstruction for Radiation Dose Reduction; 2017). SparseCT partially blocks the x-ray beam with a multislit collimator (MSC) to perform a multidimensional undersampling along the view and detector row dimensions. SparseCT undersamples the projection data within each view and moves the MSC along the z-direction during gantry rotation to change the undersampling pattern. It enables reconstruction of images from undersampled data using CS algorithms. The purpose of this work is to design the spacing and width of the MSC slits and the MSC motion patterns based on beam separation, undersampling efficiency, and image quality. The development and testing of a SparseCT prototype with the designed MSC will be described in a following paper. We chose a few initial MSC designs based on the guidance from two metrics: beam separation and undersampling efficiency. Both beam separation and undersampling efficiency were measured from numerically simulated photon distribution with MSC taken into consideration. Beam separation measures the separation between x-ray beams from consecutive slits, taking into account penumbra effects on both sides of each slit. Undersampling efficiency measures the dose-weighted similarity between penumbra undersampling and binary undersampling, in other words, the effective contribution of the incident dose to the signal to noise ratio of the projection data. We then compared the initially chosen MSC designs in terms of their reconstruction image quality. SparseCT projections were simulated from fully sampled patient projection data according to the MSC design and motion pattern, reconstructed iteratively using a sparsity-enforcing penalized weighted least squares cost function with ordered subsets/momentum algorithm, and compared visually and quantitatively. Simulated photon distributions indicate that the size of the penumbra is dominated by the size of the focal spot. Therefore, a wider MSC slit and a smaller focal spot lead to increased beam separation and undersampling efficiency. For fourfold undersampling with a 1.2mm focal spot, a minimum MSC slit width of three detector rows (projected to the detector surface) is needed for beam separation; for threefold undersampling, a minimum slit width of four detector rows is needed. Simulations of SparseCT projection and reconstruction indicate that the motion pattern of the MSC does not have a visible impact on image quality. An MSC slit width of three or four detector rows yields similar image quality. The MSC is the key component of the SparseCT method. Simulations of MSC designs incorporating x-ray beam penumbra effects showed that for threefold and fourfold dose reductions, an MSC slit width of four detector rows provided reasonable beam separation, undersampling efficiency, and image quality.

A rebirth of radiation therapy with kV X-rays?

Novel clinical approaches using kV X-ray beams are currently under study, such as selective dose enhancement in malignant tissues due to the enhanced presence of atoms with high atomic number, Z, in tumors relative to normal tissues or the use of heavily spatially fractionated kV X-ray irradiation.Local dose enhancement by high Z atoms: A substantial dose gradient between normal and malignant tissues can be achieved by biologic targeting the cells to be “destroyed” with high Z atoms and its irradiation with photons in the energy region of tens of keV, such as synchrotron produced X-rays of energy above the K-edge. The selective accumulation of high Z atoms can be achieved by various techniques, such as by intravenous administration of a) contrast enhancement agents, b) some chemotherapeutic drugs c) nanoparticles and d) DNA precursors loaded with Z-atoms. Taking into account the limited availability and the high cost of GeV synchrotrons, brachytherapy sources could be used.Microbeam radiation therapy: Studies carried out in experimental models using spatially micro- fractionated beams have shown drastically elevated tissue radiation tolerance, with higher tissue sparing in healthy tissues than in malignant ones. This phenomenon is attributed by some investigators to the proliferation and migration of cells from the “low” dosed regions (~10 Gy) to the adjacent “heavily” dosed regions (many hundreds of grays). Multi-slit collimators allow for the production of X-ray microbeam arrays at 3rd generation synchrotron units. Monte Carlo simulations were tested versus direct dose measurements. Promising preclinical studies carried out so far, trigger studies on the development of alternative less expensive technologies.

INVESTIGATING VARIABLE RBE IN A 12C MINIBEAM FIELD WITH MICRODOSIMETRY AND GEANT4.

An experimental and simulation-based study was performed on a 12C ion minibeam radiation therapy (MBRT) field produced with a clinical broad beam and a brass multi-slit collimator (MSC). Silicon-on-insulator (SOI) microdosimeters developed at the Centre for Medical Radiation Physics (CMRP) with micron sized sensitive volumes were used to measure the microdosimetric spectra at varying positions throughout the MBRT field and the corresponding dose-mean lineal energies and RBE for 10% cell survival (RBE10) were calculated using the modified Microdosimetric Kinetic Model (MKM). An increase in the average RBE10 of ∼30% and 10% was observed in the plateau region compared to broad beam for experimental and simulation values, respectively. The experimental collimator misalignment was determined to be 0.7° by comparison between measured and simulated microdosimetric spectra at varying collimator angles. The simulated dose-mean lineal energies in the valley region between minibeams were found to be higher on average than in the minibeams due to higher LET particles being produced in these regions from the MSC. This work presents the first experimental microdosimetry measurements and characterisation of the local biological effectiveness in a MBRT field.

Analytic digital tomosynthesis reconstruction in partial sampling with a multislit collimator using a prior sinogram interpolation method

This study investigated analytic digital tomosynthesis (DTS) reconstruction in partial sampling with a multislit collimator that partially blocks the x-ray beam to the patient during projection data acquisition, thereby reducing excessive radiation dose to patients. Partially-sampled DTS images reconstructed using the analytic filtered-backprojection (FBP) algorithm usually suffer from severe bright-band artifacts around multislit edges of the collimator due to incomplete spatial sampling. In this study, a new prior sinogram interpolation method was introduced to the analytic DTS reconstruction in partial sampling to alleviate such artifacts. To verify the proposed DTS method, we conducted a systematic simulation and investigated image characteristics. Three multislit collimator layouts of C(2/2), C(3/3), and C(4/4) with a 50% duty cycle were designed and used in the simulation. Here C(n/n) denotes a collimator layout that blocks the x-ray beam over n detector pixels vertically with a n-pixel interval. All projections were obtained at a tomographic angle of θ = ±40̂ and an angle step of Δθ = 2̂ and used to reconstruct DTS images using the FBP algorithm. Our results indicate that the proposed sinogram interpolation method effectively minimized bright-band artifacts in analytic DTS reconstruction in partial sampling, thus maintaining the image quality.

Implementation of planar proton minibeam radiation therapy using a pencil beam scanning system: A proof of concept study.

Proton minibeam radiation therapy (pMBRT) is an innovative approach that combines the advantages of minibeam radiation therapy with the more precise ballistics of protons to further reduce the side effects of radiation. One of the main challenges of this approach is the generation of very narrow proton pencil beams with an adequate dose-rate to treat patients within a reasonable treatment time (several minutes) in existing clinical facilities. The aim of this study was to demonstrate the feasibility of implementing pMBRT by combining the pencil beam scanning (PBS) technique with the use of multislit collimators. This proof of concept study of pMBRT with a clinical system is intended to guide upcoming biological experiments. Monte Carlo simulations (TOPAS v3.1.p2) were used to design a suitable multislit collimator to implement planar pMBRT for conventional pencil beam scanning settings. Dose distributions (depth-dose curves, lateral profiles, Peak-to-Valley Dose Ratio (PVDR) and dose-rates) for different proton beam energies were assessed by means of Monte Carlo simulations and experimental measurements in a water tank using commercial ionization chambers and a new p-type silicon diode, the IBA RAZOR. An analytical intensity-modulated dose calculation algorithm designed to optimize the weight of individual Bragg peaks composing the field was also developed and validated. Proton minibeams were then obtained using a brass multislit collimator with five slits measuring 2cm×400μm in width with a center-to-center distance of 4mm. The measured and calculated dose distributions (depth-dose curves and lateral profiles) showed a good agreement. Spread-out Bragg peaks (SOBP) and homogeneous dose distributions around the target were obtained by means of intensity modulation of Bragg peaks, while maintaining spatial fractionation at shallow depths. Mean dose-rates of 0.12 and 0.09Gy/s were obtained for one iso-energy layer and a SOBP conditions in the presence of multislit collimator. This study demonstrates the feasibility of implementing pMBRT on a PBS system. It also confirms the reliability of RAZOR detector for pMBRT dosimetry. This newly developed experimental methodology will support the design of future preclinical research with pMBRT.

Monte Carlo optimization of a microbeam collimator design for use on the small animal radiation research platform (SARRP)

Microbeam radiation therapy (MRT) is a pre-clinical, spatially-fractionated treatment modality noted for its ability to achieve a large differential response between normal and tumoral tissues. In the present study, TOPAS Monte Carlo (MC) simulations were used to optimize the design of a compact, affordable multi-slit collimator (MSC) suitable for use with the small animal radiation research platform (SARRP). MRT dose distributions in a (1 × 1 × 3)cm3 water phantom were simulated for a tungsten MSC using different focal spot sizes (0.4, 3 mm), beam energies (40, 80, 220 kVp), slit widths (100, 125, 150, 175, 200 µm), collimator thicknesses (1.5, 2.5, 3 cm) and collimator-to-surface distances (CSD of 1 and 3 cm). Key MRT figures of merit, namely the peak-to-valley dose ratio (PVDR), full-width at half-maximum and peak dose rate were determined. Use of the small focal spot maximized the PVDR (~40 at surface) and reduced the system’s sensitivity to changes in CSD, but decreased the collimated beam output to 55.2 cGy min−1. The large focal spot was ill-suited for large CSD irradiations, but increased the beam output by a factor of 2.8, to 153.0 cGy min−1, and decreased the sensitivity to changes in slit width. A modular MSC, using divergent plastic spacer materials in place of excavated slits, was also investigated. Polypropylene and polyethylene terephthalate material spacers were considered and while neither reduced the PVDR compared to air slits, the dose rate was reduced by 37% and 47%, respectively. Lastly, a steel parallel-slit MSC was used in a preliminary test of MRT delivery using the SARRP. Discrepancies between the results of film dosimetry and the corresponding MC simulations highlight the need to fabricate a more well-defined collimator for use in future validation and radiobiological work. The simulated results of this study are being used to inform the design of such a collimator, which will additionally boast a high degree of modularity at reasonable cost.

Effect of X-ray minibeam radiation therapy on clonogenic survival of glioma cells

The goal is to compare, in vitro, the efficiency of minibeam radiotherapy (MBRT) and standard RT in inducing clonogenic cell death in glioma cell lines. With this aim, we report on the first in vitro study performed in an X-ray Small Animal Radiation Research Platform (SARRP) modified for minibeam irradiations. F98 rat and U87 human glioma cells were irradiated with either an array of minibeams (MB) or with conventional homogeneous beams (broad beam, BB). A specially designed multislit collimator was used to generate the minibeams with a width of a center-to-center distance of 1465 (±10) μm, and a PVDR value of 12.4 (±2.3) measured at 1 cm depth in a water phantom. Cells were either replated for clonogenic assay directly (immediate plating, IP) or 24 h after irradiation (delayed plating, DP) to assess the effect of potentially lethal damage repair (PLDR) on cell survival. Our hypothesis is that with MBRT, a similar level of clonogenic cell death can be reached compared to standard RT, when using equal mean radiation doses. To prove this, we performed dose escalations to determine the minimum integrated dose needed to reach a similar level of clonogenic cell death for both treatments. We show that this minimum dose can vary per cell line: in F98 cells a dose of 19 Gy was needed to obtain similar levels of clonogenic survival, whereas in U87 cells there was still a slightly increased survival with MB compared to BB 19 Gy treatment.The results suggest also an impairment of DNA damage repair in F98 cells as there is no difference in clonogenic cell survival between immediately and delayed plated cells for each dose and irradiation mode. For U87 cells, a small IP-DP effect was observed in the case of BB irradiation up to a dose of 17 Gy. However, at 19 Gy BB, as well as for the complete dose range of MB irradiation, U87 cells did not show a difference in clonogenic survival between IP and DP. We therefore speculate that MBRT might influence PLDR. The current results show that X-ray MBRT is a promising method for treatment of gliomas: future preclinical and clinical studies should aim at reaching a minimum radiation (valley) dose for effective eradication of gliomas with increased sparing of normal tissues compared to standard RT.

Feasibility study on low-dosage digital tomosynthesis (DTS) using a multislit collimation technique

In this study, we investigated an effective low-dose digital tomosynthesis (DTS) where a multislit collimator placed between the X-ray tube and the patient oscillates during projection data acquisition, partially blocking the X-ray beam to the patient thereby reducing the radiation dosage. We performed a simulation using the proposed DTS with two sets of multislit collimators both having a 50% duty cycle and investigated the image characteristics to demonstrate the feasibility of this proposed approach. In the simulation, all projections were taken at a tomographic angle of θ=±50° and an angle step of Δθ=2°. We utilized an iterative algorithm based on a compressed-sensing (CS) scheme for more accurate DTS reconstruction. Using the proposed DTS, we successfully obtained CS-reconstructed DTS images with no bright-band artifacts around the multislit edges of the collimator, thus maintaining the image quality. Therefore, the use of multislit collimation in current real-world DTS systems can reduce the radiation dosage to patients.

Abstract ID: 21 Simulation of synchrotron-based microbeam radiation therapy using Geant4

Microbeam Radiation Therapy (MRT) is a preclinical radiotherapy modality characterised by the use of many micron-sized, spatially fractionated, high intensity radiation fields produced by a Multi-Slit Collimator and synchrotron light [1] . A typical MRT radiation field consists of multiple high dose ‘peaks’ separated by low dose ‘valleys’ (width 25–50 μm; pitch 100–400 μm) delivered with dose rates of up to 10 kGy/s. The minute field size and high dose rate of MRT requires good Quality Assurance in order to transition into the clinical field. Dose Verification and Treatment Planning Systems (TPS) are crucial aspects of quality assurance, allowing for independent prediction and verification of dose distributions delivered to patients. The most accurate form of TPS is Monte Carlo computer simulations. The Centre for Medical Radiation Physics (CMRP), University of Wollongong, has developed a Geant4-based synchrotron beamline model for dose verification at the Australian Synchrotron Imaging and Medical Beamline (IMBL). This model, denoted G4IMBL, uses a multi-stage procedure to generate synchrotron light, transport through the beamline model, and calculate dose deposition in a phantom. G4IMBL models the production of X-ray photons entirely using Geant4 by transporting electrons through the sinusoidal magnetic field of a wiggler. This allows for optimisation of multiple operation modes via tuning of wiggler magnetic field strength and electron steering angle. The simulation has been validated against experimental measurements and is used to characterise novel Quality Assurance silicon based detectors with sub-mm spatial resolution, developed at CMRP. The development, optimisation, and validation of this Geant4-based software tool for MRT Quality Assurance will be presented.

Carbon and oxygen minibeam radiation therapy: An experimental dosimetric evaluation.

To perform dosimetric characterization of a minibeam collimator in both carbon and oxygen ion beams to guide optimal setup geometry and irradiation for future radiobiological studies. Carbon and oxygen minibeams were generated using a prototype tungsten multislit collimator presenting line apertures 700μm wide, which are spaced 3500μm centre-to-centre distance apart. Several radiation beam spots generated the desired field size of 15×15mm2 and production of a 50mm long spread out Bragg peak (SOBP) centered at 80mm depth in water. Dose evaluations were performed with two different detectors: a PTW microDiamond® single crystal diamond detector and radiochromic films (EBT3). Peak-to-valley dose ratio (PVDR) values, output factors (OF), penumbras, and full width at half maximum (FWHM) were measured. Measured lateral dose profiles exhibited spatial fractionation of dose at depth in a water phantom in the expected form of peaks and valleys for both carbon and oxygen radiation fields. The diamond detector and radiochromic film provided measurements of PVDR in good agreement. PVDR values at shallow depth were about 60 and decreased to about 10 at 80mm depth in water. OF in the center of the SOBP was about 0.4; this value is larger than the corresponding one in proton minibeam radiation therapy measured using a comparable collimator due to a reduced lateral scattering for carbon and oxygen minibeams. Carbon and oxygen minibeams may be produced by a mechanical collimator. PVDR values and output factors measured in this first study of these minibeam radiation types indicate there is potential for their therapeutic use. Optimization of minibeam collimator design and the number and size of focal spots for irradiation are advocated to improve PDVR values and dose distributions for each specific applied use.

Optimization of the mechanical collimation for minibeam generation in proton minibeam radiation therapy.

The dose tolerances of normal tissues continue to be the main barrier in radiation therapy. To lower it, a novel concept based on a combination of proton therapy and the use of arrays of parallel and thin beams has been recently proposed: proton minibeam radiation therapy (pMBRT). It allies the inherent advantages of protons with the remarkable normal tissue preservation observed when irradiated with submillimetric spatially fractionated beams. Due to multiple Coulomb scattering, the tumor receives a homogeneous dose distribution, while normal tissues in the beam path benefit from the spatial fractionation of the dose. This promising technique has already been implemented at a clinical center (Proton therapy Center of Orsay) by means of a first prototype of a multislit collimator. The main goal of this work was to optimize the minibeam generation by means of a mechanical collimation. Monte Carlo simulations (GATE V7.1) were used to evaluate the influence of the collimator material (brass, nickel, iron, tungsten), thickness, phantom-to-collimator distance (PCD), among other parameters, on the dose distributions. Maximization of the peak-to-valley dose ratios (PVDR) in normal tissues along with minimization of full width at half maximum, penumbras and neutron contamination were used as figures of merit. As a starting point for the optimization, the collimator employed in our previous works was used. It consisted in 400 μm × 2 cm slits with a center-to-center distance (c-t-c) of 3200 μm. As the main targets of pMBRT will be neurological cases, 100 MeV energy proton minibeams were considered. This energy range would allow treating tumors located at the center of the brain (the worst scenario). Tungsten and brass are the most advantageous materials among those considered. A tungsten collimator provides the highest PVDR and lowest penumbra. Although the neutron yield generated in the tungsten collimator is 3 times higher than that of the other materials, the biologic neutron doses at the patient position amount to less than 0.05% and 0.7% of the peak and valley doses, respectively. In addition, shorter PCD than the one currently used (7 cm) leads to thinner beams (enhancing the dose-volume effects), accompanied, however, by an increase of neutron dose at the phantom surface. Finally, no gain in dose distributions is obtained by using nonparallel slits. The collimator design and irradiation configuration have been optimized to minimize the angular spread, deliver the highest PVDR and the lowest valley possible in the normal tissues in pMBRT. We have also confirmed that even though the neutron yield generated in the multislit collimator is higher with respect to the one produced by the collimators used in conventional proton therapy, the increase of biological neutron dose in the patient will remain low (less than 1%).

X-Tream quality assurance in synchrotron X-ray microbeam radiation therapy.

Microbeam radiation therapy (MRT) is a novel irradiation technique for brain tumours treatment currently under development at the European Synchrotron Radiation Facility in Grenoble, France. The technique is based on the spatial fractionation of a highly brilliant synchrotron X-ray beam into an array of microbeams using a multi-slit collimator (MSC). After promising pre-clinical results, veterinary trials have recently commenced requiring the need for dedicated quality assurance (QA) procedures. The quality of MRT treatment demands reproducible and precise spatial fractionation of the incoming synchrotron beam. The intensity profile of the microbeams must also be quickly and quantitatively characterized prior to each treatment for comparison with that used for input to the dose-planning calculations. The Centre for Medical Radiation Physics (University of Wollongong, Australia) has developed an X-ray treatment monitoring system (X-Tream) which incorporates a high-spatial-resolution silicon strip detector (SSD) specifically designed for MRT. In-air measurements of the horizontal profile of the intrinsic microbeam X-ray field in order to determine the relative intensity of each microbeam are presented, and the alignment of the MSC is also assessed. The results show that the SSD is able to resolve individual microbeams which therefore provides invaluable QA of the horizontal field size and microbeam number and shape. They also demonstrate that the SSD used in the X-Tream system is very sensitive to any small misalignment of the MSC. In order to allow as rapid QA as possible, a fast alignment procedure of the SSD based on X-ray imaging with a low-intensity low-energy beam has been developed and is presented in this publication.

SU‐F‐T‐671: Effects of Collimator Material On Proton Minibeams

Purpose:To investigate the dosimetric effects of collimator material on spatially modulated proton minibeams (pMBRT). Methods: pMBRT holds promise to exhibit shallow depth normal‐tissue sparing effects similar to synchrotron based microbeams while also retaining potential for uniform dose distributions for tumor targets. TOPAS Monte Carlo simulations were performed for a 5cm thick multislit collimator with 0.3mm slits and 1mm center‐to‐center spacing for a 50.5MeV proton minibeam while varying collimator material between brass, tungsten, and iron. The collimator was placed both “flush” at the water phantom surface and at 5cm distance to investigate the effects on surface dose, peak‐to‐valley‐dose‐ratio (PVDR) and neutron contribution.Results:For flush placement, the neutron dose at the phantom surface for the tungsten collimator was approximately 20% higher than for brass and iron. This was not reflected in the overall surface dose, which was comparable for all materials due to the relatively low neutron contribution of <0.1%. When the collimator was retracted, the overall neutron contribution was essentially identical for all three collimators. Surface dose dropped by ∼40% for all collimator materials with air gap compared to being flush with the phantom surface. This surface dose reduction was at the cost of increase in valley dose for all collimator materials due to increased angular divergence of the mini‐beams at the surface and their consequent geometric penumbra at depth. When the collimator was placed at distance from the phantom surface the PVDR decreased. The peak‐to‐entrance‐dose ratio was highest for the iron collimator with 5cm air gap. Conclusion: The dosimetric difference between the collimator materials is minimal despite the relatively higher neutron contribution at the phantom surface for the tungsten collimator when placed flush. The air gap between the collimator and phantom surface strongly influences all dosimetry parameters due to the influence of scatter on the narrow spatial modulation.

A comparison of two prompt gamma imaging techniques with collimator-based cameras for range verification in proton therapy

In vivo range verification plays an important role in proton therapy to fully utilize the benefits of the Bragg peak (BP) for delivering high radiation dose to tumor, while sparing the normal tissue. For accurately locating the position of BP, camera equipped with collimators (multi-slit and knife-edge collimator) to image prompt gamma (PG) emitted along the proton tracks in the patient have been proposed for range verification. The aim of the work is to compare the performance of multi-slit collimator and knife-edge collimator for non-invasive proton beam range verification. PG imaging was simulated by a validated GATE/GEANT4 Monte Carlo code to model the spot-scanning proton therapy and cylindrical PMMA phantom in detail. For each spot, 108 protons were simulated. To investigate the correlation between the acquired PG profile and the proton range, the falloff regions of PG profiles were fitted with a 3-line-segment curve function as the range estimate. Factors including the energy window setting, proton energy, phantom size, and phantom shift that may influence the accuracy of detecting range were studied. Results indicated that both collimator systems achieve reasonable accuracy and good response to the phantom shift. The accuracy of range predicted by multi-slit collimator system is less affected by the proton energy, while knife-edge collimator system can achieve higher detection efficiency that lead to a smaller deviation in predicting range. We conclude that both collimator systems have potentials for accurately range monitoring in proton therapy. It is noted that neutron contamination has a marked impact on range prediction of the two systems, especially in multi-slit system. Therefore, a neutron reduction technique for improving the accuracy of range verification of proton therapy is needed.

Collimator Design for a Brain SPECT/MRI Insert

This project’s goal is to design a SPECT insert for a clinical MRI system for simultaneous brain SPECT/MR imaging, with a high-sensitivity collimator and high-resolution detectors. We have compared eight collimator designs, four multi-pinhole and four multi-slit slit-slat configurations. The collimation was designed for a system with rings of 25 $5\times 5~\hbox{cm}$ detectors. We introduce the concept of 1/2-pinhole and 1/2-slit, which are transaxially shared between two adjacent detectors. Analytical geometric efficiency was calculated for an activity distribution corresponding to a human brain and a range of intrinsic detector resolutions ${\rm R}_i$ and target resolutions ${\rm R}_t$ at the centre of the FOV. Noise-free data were simulated with and without depth-of-interaction (DOI) information, 0.8 mm ${\rm R}_i$ and 10 mm ${\rm R}_t$ FWHM, and reconstructed for uniform, Defrise, Derenzo, and Zubal brain phantoms. Comparing the multi-pinhole and multi-slit slit-slat collimators, the former gives better reconstructed uniformity and transaxial resolution, while the latter gives better axial resolution. Although the $2 \times 2$ -pinhole and 2-slit designs give the highest sensitivities, they result in a sub-optimal utilisation of the detector FOV. The best options are therefore the $ 5+ 2 1/2$ -pinhole and the $1 + 2 1/2$ -slit systems, with sensitivities of $1.8 \times {10^{ - 4}}$ and $3.2 \times {10^{ - 4}}$ , respectively. Noiseless brain phantom reconstructions with the multi-pinhole collimator are slightly superior as compared to slit-slat, in terms of symmetry and accuracy of the activity distribution, but the same is not true when noise is included. DOI information reduces artefacts and improves uniformity in geometric phantoms. Further evaluation is needed with prototype collimators.

On the design and experimental realization of a multislit-based very small angle neutron scattering instrument at the European Spallation Source

This article reports the design of a versatile multislit-based very small angle neutron scattering (VSANS) instrument working either as a dedicated instrument or as an add-on for any small-angle neutron scattering machine like the proposed SANS instrument, SKADI, at the future European Spallation Source. The use of multiple slits as a VSANS collimator for the time-of-flight techniques has been validated using McStas simulations. Various instrument configurations to achieve different minimum wavevector transfers in scattering experiments are proposed. The flexibility of the multislit VSANS instrument concept is demonstrated by showing the possibility of instrument length scaling for the first time, allowing access to varying minimum wavevector transfers with the same multislit setup. These options can provide smooth access to minimum wavevector transfers lower than ∼4 × 10−5 Å−1 and an overlapping of wavevector coverage with normal SANS mode, e.g. with the SKADI wavevector range of 10−3–1.1 Å−1. Such an angularly well defined and intense neutron beam will allow faster SANS studies of objects larger than 1 µm. Calculations have also been carried out for a radial collimator as an alternative to the multislit collimator setup. This extends the SANS Q range by an order of magnitude to 1 × 10−4 Å−1 with much simpler alignment. The multislit idea has been realized experimentally by building a prototype at Laboratoire Leon Brillouin, Saclay, with cross-talk-free geometry. Feasibility studies were carried out by making VSANS measurements with single- and multislit collimators, and the results are compared with multiple-pinhole geometry using classical SANS analysis tools.

Medical physics aspects of the synchrotron radiation therapies: Microbeam radiation therapy (MRT) and synchrotron stereotactic radiotherapy (SSRT)

Stereotactic Synchrotron Radiotherapy (SSRT) and Microbeam Radiation Therapy (MRT) are both novel approaches to treat brain tumor and potentially other tumors using synchrotron radiation. Although the techniques differ by their principles, SSRT and MRT share certain common aspects with the possibility of combining their advantages in the future. For MRT, the technique uses highly collimated, quasi-parallel arrays of X-ray microbeams between 50 and 600 keV. Important features of highly brilliant Synchrotron sources are a very small beam divergence and an extremely high dose rate. The minimal beam divergence allows the insertion of so called Multi Slit Collimators (MSC) to produce spatially fractionated beams of typically ∼25–75 micron-wide microplanar beams separated by wider (100–400 microns center-to-center(ctc)) spaces with a very sharp penumbra. Peak entrance doses of several hundreds of Gy are extremely well tolerated by normal tissues and at the same time provide a higher therapeutic index for various tumor models in rodents. The hypothesis of a selective radio-vulnerability of the tumor vasculature versus normal blood vessels by MRT was recently more solidified.SSRT (Synchrotron Stereotactic Radiotherapy) is based on a local drug uptake of high-Z elements in tumors followed by stereotactic irradiation with 80 keV photons to enhance the dose deposition only within the tumor. With SSRT already in its clinical trial stage at the ESRF, most medical physics problems are already solved and the implemented solutions are briefly described, while the medical physics aspects in MRT will be discussed in more detail in this paper.

Microbeam radiation therapy: a review

The radiation effects in tissue depend not only on dose but also on volume exposed, for example, the smaller the volume, the greater the tolerance. Microbeam radiation therapy (MRT), which exploits this effect, can only be achieved with synchrotron X-rays owing to their extraordinarily slight divergence. MRT research over the past 20 years has yielded many results from preclinical trials based on different animal models, including mice, rats, piglets and rabbits. Typically, targets are exposed to multiple quasi-parallel slices of radiation some tens of micrometres wide with on-centre separations of several hundred micrometres. The microplanar beams are produced by a multi-slit collimator, which cuts horizontally microscopic beam sectors from a wiggler-generated fan beam. Peak entrance doses of several hundreds of Gy are surprisingly well tolerated by normal tissues and at the same time show a preferential damage of malignant tumour tissues.